Last reviewed · How we verify
NCT06234371
Financial Incentives for Veteran Therapy Completion
NA trial testing Financial Incentive in Motivation in 600 participants. Enrolling by invitation.
2 January 2027
Quick facts
| Lead sponsor | Christopher Cronin |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 600 |
| Start date | 2 January 2024 |
| Primary completion | 2 January 2027 |
| Estimated completion | 2 January 2028 |
| Sites | 3 locations across United States |
Drugs / interventions tested
- Financial Incentive
Conditions studied
- Motivation — all drugs for Motivation →
- Stress Disorder — all drugs for Stress Disorder →
- Post Traumatic Stress Disorder — all drugs for Post Traumatic Stress Disorder →
- Depression — all drugs for Depression →
Sponsor
Christopher Cronin
Who can join
18 and older, any sex, with Motivation or Stress Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Recovery Resource Council (RRC) is one of the largest and most comprehensive non-profit mental and behavioral healthcare providers in North Texas. Accredited by the Joint Commission in Behavioral Health and licensed by the State of Texas as an Outpatient Treatment Center, RRC strives to promote wellness and recovery through a variety of services and programming. An important component of RRC programming is providing free counseling services to hundreds of U.S. veterans annually. While RRC observes great success for veterans who complete counseling, attendance can be a major obstacle. Veterans who approach RRC for individual counseling services and consent to participate will be randomly assigned to the treatment or control group. The control group will receive counseling as usual. The treatment group will receive $500 gift card payments upon completing their 6th, 12th, and 18th counseling sessions, i.e., $1,500 in gift cards for completing all 18 sessions, the usual prescribed length of therapy. Our primary focus is to examine the impact of the financial incentives on therapy attendance and attrition. In addition, the investigators will estimate the impact on mental health using mental health inventories collected over the course of therapy sessions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06234371
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Financial Incentive
Trials testing the same drug.
- NCT07218120 — In-Person Recruitment of Individuals to the Alzheimer's Prevention Trial (APT) Webstudy · NA · recruiting
- NCT06300242 — Incentives for Influenza Vaccination · NA · completed
- NCT06133816 — Lung Cancer Screening Eligibility Assessment · NA · completed
- NCT05648773 — COVID-19 Booster Incentives · NA · completed
- NCT04328207 — Providing Financial Incentives to Improve Adherence to Referral Eye Care Visits · NA · completed
Other recruiting trials for Motivation
Currently open trials in the same condition.
- NCT07413185 — Relationship Between the Severity of Sleep Deprivation in the First 48 Hours Postpartum, Breastfeeding Motivation, and B · recruiting
- NCT07067554 — Breastfeeding Myths and Mothers' Motivation · recruiting
- NCT07113067 — Accelerated rTMS vs. Sham for Stroke Apathy · Phase 1, PHASE2 · recruiting
- NCT06826703 — The Effect of Motivational Interviewing on Diabetes Self-Management and Severity of Cyberchondria in Individuals With Di · NA · recruiting
- NCT07143123 — Enhancing Nursing Skills With SimCapture Technology · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06234371 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Christopher Cronin
- Last refreshed: 18 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06234371.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing